The Medical Advisor

A research group from Mexico investigated Ivermectin in Cancer. This is the first study that has tested as many as 28 Cancer types with Ivermectin.  Paper: 2020 (Juarez et al) - Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.  Ivermectin was tested at 2mg/kg/day which translates to roughly 5uM in vitro concentration. The most sensitive cancer cell lines were: 1. Ovarian 2. Breast 3. Glioblastoma 4. Lung Cancer 5. Colon Cancer 6. Uterine SCC 7. hepatocellular 8. breast TNBC 9. Pancreatic 10. Endometrial. Least sensitive were: 1. osteosarcoma 2. gastric 3. melanoma  Although lymphoma and leukemia cell lines appear to be more resistant to Ivermectin, Ivermectin has a significant impact on those cells' ability to form colonies. So yes, Ivermectin is useful against BOTH lymphomas and leukemias.  Ivermectin also goes after CANCER STEM CELLS, which tend to be resistant to chemotherapy: ...

Integrative Pain Medicine · OneDayMD The suppressed decades of evidence showing how Dimethyl Sulfoxide revolutionises the treatment of pain — safely, effectively, and at a fraction of the cost of conventional drugs. Updated June 2026  |  Evidence-Based Review  |  OneDayMD Editorial Team Medical Disclaimer: This article is for educational and informational purposes only. DMSO is not FDA-approved for the indications discussed. Do not use DMSO without consulting a qualified healthcare provider. Never apply DMSO over skin that has been exposed to toxic substances. This article does not constitute medical advice. Story at a Glance ▶ The standard approach for treating pain relies on NSAIDs (e.g., ibuprofen) and opioids — drugs that each kill tens of thousands of people per year yet remain the standard of care. ▶ DMS...